Loading…

Acetylcholinesterase inhibitory effects of the bulb of Ammocharis coranica (Amaryllidaceae) and its active constituent lycorine

Ammocharis coranica (Ker-Gawl.) Herb. (Amaryllidaceae) is used in southern Africa for the treatment of mental illnesses. The ethanol extracts of the bulb of A. coranica and its total alkaloids rich fractions were screened for inhibition of acetylcholinesterase enzyme (AChE), which is implicated in t...

Full description

Saved in:
Bibliographic Details
Published in:South African journal of botany 2013-03, Vol.85, p.44-47
Main Authors: Elisha, I.L., Elgorashi, E.E., Hussein, A.A., Duncan, G., Eloff, J.N.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ammocharis coranica (Ker-Gawl.) Herb. (Amaryllidaceae) is used in southern Africa for the treatment of mental illnesses. The ethanol extracts of the bulb of A. coranica and its total alkaloids rich fractions were screened for inhibition of acetylcholinesterase enzyme (AChE), which is implicated in the pathophysiology of Alzheimer's disease. The ethanolic extracts significantly inhibited AChE with IC50 value of 14.3±0.50μg/ml. The basic ethyl acetate and butanol fractions of the crude extracts were the most active against AChE with IC50 values of 43.1±1.22 and 0.05±0.02μg/ml respectively. Bioassay-guided fractionation of the basic fractions led to the isolation of lycorine and 24-methylenecycloartan-3β-ol. Lycorine which was isolated from both butanol and ethyl acetate fractions had IC50 of 29.3±3.15μg/ml, while 24-methylenecycloartan-3β-ol was not active. ► The acetylcholinesterase activity of Ammocharis coranica was investigated for the first time. ► The alkaloid rich butanol fraction had 30 times higher activity than physostigmine. ► Lycorine was identified as the major active compound. ► Results support the use of A. coranica in traditional medicine for treatment of mental illnesses.
ISSN:0254-6299
1727-9321
DOI:10.1016/j.sajb.2012.11.008